IL-12而非免疫检查点抑制剂助力HDV特异性T细胞功能恢复
该研究在49例HDV感染者、25例HBV单感染者和18例健康对照中分析免疫细胞频率与表型,并用重叠肽段刺激评估T细胞增殖与细胞因子产生能力。结果显示HDV特异性T细胞反应微弱,阻断PD-1通路仅部分恢复,而添加IL-12可更稳健且一致地增强HDV特异性CD4+和CD8+ T细胞反应。
要点
- HDV感染者CD8+ T细胞中衰老标志物CD57显著上调。
- 阻断PD-1通路仅部分恢复HDV特异性T细胞反应。
- 添加IL-12可更稳健增强HDV特异性CD4+和CD8+ T细胞反应。
核心结论
- HDV感染患者存在免疫细胞早衰和T细胞功能受损,补充IL-12而非仅阻断抑制性通路可更有效恢复HDV特异性T细胞功能。
研究设计与样本
- 研究纳入49例HDV感染者、25例HBV单感染者和18例健康对照,检测免疫细胞频率与表型。
- 用覆盖大HDV抗原的重叠肽段刺激分析T细胞增殖和细胞因子产生能力。
- 使用抗CTLA-4、抗PD-L1阻断抗体或促炎细胞因子IL-12以恢复T细胞反应。
主要发现
- 各组间免疫细胞频率和表型无差异,仅HDV感染者CD8+ T细胞中CD57显著上调。
- HDV特异性T细胞增殖和细胞因子产生微弱,阻断PD-1通路仅部分挽救。
- 添加IL-12后HDV特异性CD4+和CD8+ T细胞反应更稳健且一致地增加,并影响CMV和EBV特异性T细胞。
临床怎么用
- HDV感染者T细胞功能受损,评估免疫衰老标志物如CD57可能有助于识别免疫功能障碍。
- IL-12补充或为恢复HDV特异性T细胞功能的潜在免疫干预策略,但需进一步临床验证。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis D virus (HDV) infection affects 15-20 million individuals worldwide and causes severely progressive hepatitis. It is unknown to what extent cellular immune responses contribute to liver disease and control of viral replication in HDV infection. METHODS: Immune cell frequencies and phenotypes were determined in 49 HDV-infected patients, 25 individuals with hepatitis B virus monoinfection and 18 healthy controls. T-cell proliferative and cytokine-producing capacities were analyzed by stimulation with overlapping peptides spanning the large HDV antigen. To restore T-cell responses, blocking antibodies (anti-cytotoxic T-lymphocyte antigen 4, anti-programmed death ligand 1) or proinflammatory cytokines (interleukin [IL] 12) were used. RESULTS: Immune cell frequencies and phenotypes did not vary between the groups. Exclusively, the senescence marker CD57 was significantly up-regulated in CD8+ T cells from patients with hepatitis delta. HDV-specific T-cell proliferation and cytokine production were weak and could only partly be rescued by blockade of the programmed death 1 pathway. However, a more robust and consistent increase in HDV-specific CD4+ and CD8+ T-cell responses was evident when the third signal cytokine IL-12 was added, which also affected cytomegalovirus- and Epstein-Barr virus-specific T cells. CONCLUSIONS: This investigation of virus-specific T-cell immunity in patients with HDV infection, the largest to date, revealed premature aging of immune cells and impaired T-cell functionality. This could be restored by blocking inhibitory pathways and, in particular, by supplementing with IL-12.
引用
- Schirdewahn T, Grabowski J, Owusu Sekyere S, et al. The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells. J Infect Dis. 2016. PMID: 27803174. doi:10.1093/infdis/jiw514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。